We are live on ! Find out more
OQS

Occudo Quantitative Strategies Portfolio holdings

AUM $1.84B
1-Year Est. Return 22.15%
This Fund
S&P 500
This Quarter Est. Return
+9.17%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
AUM
$859M
AUM Growth
-$429M
Cap. Flow
-$442M
Cap. Flow %
-51.43%
Top 10 Hldgs %
4.21%
Holding
1,520
New
386
Increased
181
Reduced
340
Closed
602

Top Buys

Rank Stock Value
1
GOSS icon
Gossamer Bio
GOSS
+$5.95M
2
MRVL icon
Marvell Technology
MRVL
+$4M
3
AAPL icon
Apple
AAPL
+$3.97M
4
DIS icon
Walt Disney
DIS
+$3.95M
5
ROL icon
Rollins
ROL
+$3.82M

Top Sells

Rank Stock Value
1
DDOG icon
Datadog
DDOG
+$7.11M
2
ICE icon
Intercontinental Exchange
ICE
+$6.91M
3
XRAY icon
Dentsply Sirona
XRAY
+$6.81M
4
CSCO icon
Cisco
CSCO
+$6.77M
5
QRVO icon
Qorvo
QRVO
+$6.72M

Sector Composition

Rank Sector Weight
1 Technology 21.95%
2 Consumer Discretionary 16.59%
3 Industrials 13.62%
4 Financials 13.07%
5 Healthcare 7.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIR icon
1401
Vir Biotechnology
VIR
$1.53B
-14,815
Closed -$286K
VLY icon
1402
Valley National Bancorp
VLY
$8.06B
-296,803
Closed -$3.21M
VNDA icon
1403
Vanda Pharmaceuticals
VNDA
$315M
-65,773
Closed -$650K
VRCA icon
1404
Verrica Pharmaceuticals
VRCA
$92.8M
-1,776
Closed -$52K
VRDN icon
1405
Viridian Therapeutics
VRDN
$2.23B
-15,764
Closed -$323K
VREX icon
1406
Varex Imaging
VREX
$507M
-19,380
Closed -$410K
VRRM icon
1407
Verra Mobility
VRRM
$835M
-20,216
Closed -$311K
VRSK icon
1408
Verisk Analytics
VRSK
$24.9B
-6,596
Closed -$1.13M
VTRS icon
1409
Viatris
VTRS
$20.5B
-56,134
Closed -$478K
VTYX
1410
DELISTED
Ventyx Biosciences
VTYX
-18,936
Closed -$661K
VVV icon
1411
Valvoline
VVV
$4.95B
-35,757
Closed -$906K
VYGR icon
1412
Voyager Therapeutics
VYGR
$184M
-26,593
Closed -$157K
W icon
1413
Wayfair
W
$14.9B
-112,124
Closed -$3.65M
WABC icon
1414
Westamerica Bancorp
WABC
$1.39B
-3,980
Closed -$208K
WAL icon
1415
Western Alliance Bancorporation
WAL
$9.11B
-18,873
Closed -$1.24M
WDAY icon
1416
Workday
WDAY
$41B
-10,923
Closed -$1.66M
WK icon
1417
Workiva
WK
$3.46B
-37,902
Closed -$2.95M
WLK icon
1418
Westlake Corp
WLK
$9.79B
-5,582
Closed -$485K
WMS icon
1419
Advanced Drainage Systems
WMS
$11.3B
-49,069
Closed -$6.1M
WOLF icon
1420
Wolfspeed
WOLF
$1.36B
-5,129
Closed -$530K
WOR icon
1421
Worthington Enterprises
WOR
$2.79B
-38,542
Closed -$906K
WRB icon
1422
W.R. Berkley
WRB
$26.5B
-17,930
Closed -$772K
WSC icon
1423
WillScot Mobile Mini Holdings
WSC
$4.72B
-29,446
Closed -$1.19M
WST icon
1424
West Pharmaceutical
WST
$24.4B
-14,825
Closed -$3.65M
WTI icon
1425
W&T Offshore
WTI
$509M
-38,715
Closed -$227K

Similar funds

Occudo Quantitative Strategies's Q4 2022 Portfolio in Review

As of Q4 2022, Occudo Quantitative Strategies held 1,520 positions worth $859M, down 33% from $1.29B the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

Occudo Quantitative Strategies withdrew a net $442M in Q4 2022, closing 602 positions and reducing 340 holdings. Its most notable exit was Datadog, an estimated $7.11M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Occudo Quantitative Strategies opened a new position in Marvell Technology worth $3.63M.

  • Occudo Quantitative Strategies's largest Q4 2022 buy was Marvell Technology: 97,934 shares worth $3.63M.
  • Occudo Quantitative Strategies added most to Gossamer Bio in Q4 2022, an estimated $5.95M increase.
  • Occudo Quantitative Strategies's biggest Q4 2022 reduction was Align Technology, cutting an estimated $6.27M.
  • Occudo Quantitative Strategies fully exited Datadog in Q4 2022, selling an estimated $7.11M.
  • Occudo Quantitative Strategies's ten largest holdings make up 4.2% of its $859M portfolio in Q4 2022.
  • Occudo Quantitative Strategies opened 386 new positions and closed 602 in Q4 2022.
  • Occudo Quantitative Strategies's portfolio value fell 33% quarter-over-quarter to $859M.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.